The study highlights HelixVM’s significant economic and operational impact on partner businesses, showcasing its tremendous potential within the healthcare ecosystem.
(PRUnderground) December 13th, 2024
HITLAB, the premier organization advancing digital health innovation, today announced the findings of its Level 3 Study on HelixVM, a transformative telemedicine platform. The study highlights HelixVM’s significant economic and operational impact on partner businesses, showcasing its tremendous potential within the healthcare ecosystem.
Referral partners surveyed in the study included key organizations requiring medical orders—such as orthotic and prosthetic companies, sleep evaluation and diagnostic firms, and workers’ compensation organizations serving employers and insurers. The results highlight HelixVM’s ability to deliver measurable financial and operational benefits:
- Revenue Growth: Partners reported generating between $300 and $10,000 per customer using the HelixVM platform, with one organization attributing 75% of their total revenue directly to the platform’s innovative solutions.
- Improved Efficiency: Beyond financial impact, the platform enables seamless integration with health insurance systems, improving speed and streamlining operations.
HelixVM empowers its partners to leverage technology for improved patient outcomes and operational success, bridging gaps in care delivery and enabling better collaboration across the healthcare ecosystem.
“Our latest study demonstrates HelixVM’s ability to drive unparalleled value for its partners, transforming their operations while ensuring revenue growth and efficiency,” said Stan Kachnowski, Chair at HITLAB. “This platform is not just a technological solution—it’s a key driver of change in how healthcare is delivered, managed, and valued.”
As the healthcare industry faces increasing demand for cost-effective and efficient solutions, HelixVM is poised to play a pivotal role in helping organizations optimize their processes, leverage insurance capabilities, and enhance their bottom lines.
Validated by Providers and Patients
The HelixVM platform has also been rigorously evaluated for its usability and effectiveness through a mixed-methods study published in the JMIR Formative Research Journal. The findings revealed overwhelming satisfaction:
- 86.3% of patients reported satisfaction with HelixVM, while 89.2% indicated they would use the service again.
- 91.1% of patients agreed that HelixVM improves access to care and enhances healthcare delivery.
- 98% of patients noted that the platform saves time.
- Providers also cited positive experiences with the platform, highlighting its asynchronous care delivery model, workflow integration, and AI-powered triage.
- The study confirmed HelixVM’s potential to improve productivity, data exchange, and the quality of care.
HelixVM’s Broader Impact
Beyond its financial impact, HelixVM empowers businesses to enhance operational efficiency and healthcare accessibility, making it a vital asset in the ever-evolving healthcare landscape. The platform continues to transform how healthcare providers and organizations collaborate, further solidifying its position in the telehealth space.
For more information on HelixVM and to explore the full Level 3 study, visit here.
About HITLAB
HITLAB is an impact-first organization that offers digital health research, teaching, and advisory services to improve health delivery around the world.
At HITLAB, we believe technology and health can work together to improve the quality of health delivery and healthcare worldwide. We use rigorous research and evidence-based methods to identify the best digital health solutions for each of our partners.
The post HITLAB Study Confirms HelixVM’s Impact on Partner Revenue and Efficiency first appeared on
Original Press Release.
